According to Lipocine's latest financial reports the company's current EPS (TTM) is -$2.21. In 2022 the company made an earnings per share (EPS) of -$2.03 a decrease over its 2021 EPS that were of -$0.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.21 | 8.87% |
2022 | -$2.03 | 1094.12% |
2021 | -$0.17 | -97.5% |
2020 | -$6.80 | -20% |
2019 | -$8.50 | -9.09% |
2018 | -$9.35 | -47.12% |
2017 | -$17.68 | -0% |
2016 | -$17.68 | -4.93% |
2015 | -$18.60 | -31.63% |
2014 | -$27.20 | 74.47% |
2013 | -$15.59 | -99.35% |
2012 | -$2,392 |